San Diego, CA, United States of America

Doug Taylor

This inventor holds 1 USPTO granted patent. Top assignee: Phyton Holdings, LLC. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Doug Taylor. Retrieved from https://idiyas.com/inventor/doug-taylor-fli6agiw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Doug Taylor – A Pioneer in Immunoglobulin Production

Introduction

Doug Taylor is an innovative inventor based in San Diego, California. With his unique contribution to the field of biotechnology, he has made strides in the production of immunoglobulins. His work reflects a commitment to enhancing the efficacy of biologically active compounds through advanced methods.

Latest Patents

Doug holds a patent titled "Plant production of immunoglobulins with reduced fucosylation." This invention addresses the plant-based production of immunoglobulins, specifically focusing on creating variants that possess glycans with reduced fucose content. Such modifications can significantly impact the therapeutic potential and effectiveness of immunoglobulins. The patent includes a variety of constructs, plasmids, and transformed plant materials used for the production of these modified immunoglobulins, along with outlined methods for their synthesis and application.

Career Highlights

As an inventor at Phyton Holdings, LLC, Doug has utilized his expertise to pioneer approaches that leverage plant biotechnology for medical applications. His innovative mindset and technical solutions have allowed him to make notable advancements in agricultural biotechnology and therapeutic developments.

Collaborations

Doug collaborates with talented colleagues like Kristen Briggs and Todd Glancy, who share a commitment to advancing the field. Their collaborative efforts at Phyton Holdings exemplify the synergy that can be achieved in research and development environments, leading to groundbreaking innovations.

Conclusion

Doug Taylor's contributions to the field of immunoglobulin production reflect his dedication to innovation and scientific progress. Through his patent, he is helping to spearhead new methods in biotechnology that could transform therapeutic solutions, highlighting the importance of inventors like him in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…